OpView image processing software reconstructs breast images obtained from full-field digital mammography, as well as ultrasound and MRI, to bring clarity to challenging breast scans. The software, unveiled Sunday at the RSNA meeting by Siemens Medical Solutions, will assist interpretation of lesions in dense breasts and microcalcifications, according to the company.
OpView image processing software reconstructs breast images obtained from full-field digital mammography, as well as ultrasound and MRI, to bring clarity to challenging breast scans. The software, unveiled Sunday at the RSNA meeting by Siemens Medical Solutions, will assist interpretation of lesions in dense breasts and microcalcifications, according to the company.
Running in concert with visualization features built into Siemens' syngo-based workstations, OpView can be used to adjust the display of images to concentrate on areas of high interest, such as the borders of the breast and subtle masses, or to adjust brightness and contrast for optimal display of images.
The software decreases the quantum and electronic noise from x-rays that can interfere with the evaluation of suspicious lesions, particularly abnormalities that are low in contrast. An edge enhancement feature enhances high frequencies in an image to increase the visibility of structures such as microcalcifications.
In addition to the multimodality Mammomat Novation syngo-based acquisition workstation, OpView can be used with the MammoReport workstation, which incorporates computer-aided detection (CAD) markers from various vendors.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.